30.06.2013 Views

Introduction to Health Physics: Fourth Edition - Ruang Baca FMIPA UB

Introduction to Health Physics: Fourth Edition - Ruang Baca FMIPA UB

Introduction to Health Physics: Fourth Edition - Ruang Baca FMIPA UB

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

406 CHAPTER 8<br />

For dosimetric purposes, six nonexclusive categories of bone seekers are used in<br />

the ICRP 30 bone model:<br />

1. pho<strong>to</strong>n emitters,<br />

2. alpha-emitting volume seekers,<br />

3. alpha-emitting surface seekers,<br />

4. beta-emitting surface seekers whose mean beta energy is at least 0.2 MeV,<br />

5. beta-emitting surface seekers whose mean beta energy is less than 0.2 MeV, and<br />

6. beta-emitting volume seekers.<br />

These categories are not mutually exclusive because a radionuclide, such as a beta–<br />

gamma emitter, belongs in two categories. In this case, each different type of radiation<br />

is considered separately. The AF for the various particle emitters are given in<br />

Table 8-23. The AFs for pho<strong>to</strong>ns are given in Appendix D.<br />

Using the physiologically based biokinetic model for a bone-seeking radionuclide,<br />

we can calculate the dose <strong>to</strong> the bone or bone surface and the doses <strong>to</strong> the<br />

other organs and tissues due <strong>to</strong> the intake, by ingestion or inhalation, of 1 Bq or 1<br />

μCi of activity. Then, using either the ICRP and IAEA criterion of 0.02-Sv effective<br />

dose limit, or U.S. NRC criterion of 5-rems (0.05-Sv) effective dose limit or 50-rems<br />

(0.5-Sv) organ dose limit, or we can calculate the secondary ALI and the tertiary<br />

DAC or maximum concentration in water. If we were <strong>to</strong> use the ICRP criterion of<br />

a mean annual effective dose of 0.02 Sv and the DC of 2.4 × 10−9 Sv/Bq for 5-μm<br />

moderately soluble 45Ca particles, then the inhalation ALI would be<br />

0.02 Sv<br />

ALI(effective) =<br />

= 8.33 × 10<br />

−9 Sv<br />

2.4 × 10<br />

Bq<br />

6 Bq = 225 μCi.<br />

For example, the U S NRC’s inhalation ALI for soluble (class D) 90 Sr, using the DCs<br />

for the bone surface and for whole-body effective dose listed in Table 8-20, we have<br />

0.5Sv<br />

ALI(bone surface) =<br />

= 6.86 × 10<br />

Sv<br />

7.29 × 10−7 Bq<br />

5 Bq = 1.86 × 10 1 μCi<br />

0.05 Sv<br />

ALI(effective) =<br />

= 7.73 × 10<br />

Sv<br />

6.47 × 10−8 Bq<br />

5 Bq = 2.09 × 10 1 μCi.<br />

TABLE 8-23. Recommended Absorbed Fractions for Dosimetry of Radionuclides in Bone<br />

A, α, β, β, Ē ≥ 0.2 β, Ē < 0.2<br />

SOURCE TARGET Vol. BS Vol. MeV, BS MeV, BS<br />

Trabecular Surface (BS) 0.025 0.25 0.025 0.025 0.25<br />

Cortical Surface 0.01 0.25 0.015 0.015 0.25<br />

Trabecular Red Marrow 0.05 0.5 0.35 0.5 0.5<br />

Cortical Red Marrow 0.0 0.0 0.0 0.0 0.0<br />

Abbreviation: BS, bone surface.<br />

Reproduced with permission from ICRP Publication 30, Part 1: Limits for Intakes of Radionuclides by Workers. Ann ICRP.<br />

1979; 2(3/4):42. Copyright c○ 1979 International Commission on Radiological Protection.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!